Pulmonary arterial hypertension (PAH) is a rare and chronic lung vasculature disease
characterised by pulmonary vasculature remodelling, including abnormal proliferation of …

Huang-Lian-Jie-Du decoction (HLJDD) has been widely applied to treat inflammation-
associated diseases for thousands of years in China. However, the concrete molecular …

Background: Pulmonary arterial hypertension (PAH) is a life-threatening chronic
cardiopulmonary disease. However, there are limited studies reflecting the available …

Pulmonary arterial hypertension (PAH) is a progressive and complex pulmonary vascular
disease with poor prognosis. The aim of this study was to provide a new understanding of …

Background: Previous studies revealed that the gene signatures are associated with the
modulation and pathogenesis of pulmonary arterial hypertension (PAH). However …

Background Pulmonary artery hypertension (PAH) is an incurable disease with a high
mortality rate. Current medications ameliorate symptoms but cannot target adverse vascular …

Idiopathic pulmonary arterial hypertension (IPAH) is a progressive vascular disease with
high mortality and heritability. Pyroptosis is a novel form of programmed cell death, and it is …

Pulmonary arterial hypertension (PAH) is a severe cardiovascular disorder with high
mortality. Multiple clinical diseases can induce PAH, but the underlying molecular …

Idiopathic pulmonary arterial hypertension (IPAH) is a progressive disease that affects the
pulmonary arteries, resulting in increased pulmonary vascular resistance and right …

Abstracts Objective Pulmonary artery hypertension (PAH) is a complex, fatal disease with
limited treatments. This study aimed to investigate possible key targets in PAH through …